Virkasafe Tablet
Marketer
Concur Pharmaceuticals Pvt.Ltd
Salt Composition
Taurine (500mg) + Acetylcysteine (150mg)
Overview Virkasafe Tablet
RenalGuard tablets combine medications to manage chronic kidney disease, safeguarding kidney function and mitigating the risk of renal failure. Administer RenalGuard with or without food, following your physician's prescribed dosage and regimen. Dosage is individualized based on your health status and response to treatment. Continue this medication as directed by your doctor; premature discontinuation may lead to symptom recurrence and disease progression. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, vomiting, fever, rhinorrhea, diarrhea, abdominal discomfort, skin rash or irritation, and pharyngitis. These are typically transient and self-limiting. Report any concerning side effects to your doctor immediately. Prior to initiating treatment, disclose any existing kidney or liver conditions, as well as all other medications you are currently taking. Pregnant or breastfeeding individuals should seek medical counsel before using RenalGuard.
Uses of Virkasafe Tablet
Managing Chronic Kidney Failure
Major Benefits of Virkasafe Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Virkasafe Tablet with a meal.
Common Side effects of Virkasafe Tablet:
- Nausea
- Vomiting
- Rash
- Fever
- Runny nose
- Diarrhea
- Abdominal pain
- Skin irritation
- Throat irritation
How to use Virkasafe Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Virkasafe Tablets. Ingest each tablet whole; avoid chewing, crushing, or breaking it. Administer Virkasafe with a meal.
How Virkasafe Tablet works:
Taurine and Acetylcysteine, the active components of Virkasafe Tablet, function synergistically as antioxidants to safeguard renal tissue from the damaging effects of free radicals.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Virkasafe Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals may experience adverse effects from Virkasafe Tablets. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the risks and advantages before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Virkasafe Tablet while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Virkasafe Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Virkasafe Tablets without requiring any dosage modification.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Virkasafe Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Virkasafe Tablet :
Should you forget to take a Virkasafe Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Virkasafe Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urological Care |
3,018 People bought this recently